Phase 1 Study Accessing the Safety and Tolerability of CBP-307
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of
CBP-307 following oral single and multiple escalating dose administration in healthy
subjects.